N
0.866
0.00 (0.44%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Nautilus Biotechnology, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
-0.8
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.83 |
|
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 33.38% |
| 机构持股比例 | 48.76% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ah Capital Management, L.L.C. | 30 Jun 2025 | 17,653,917 |
| Madrona Venture Group, Llc | 30 Jun 2025 | 6,020,770 |
| Clarius Group, Llc | 30 Jun 2025 | 1,060,460 |
| Tikvah Management Llc | 30 Jun 2025 | 726,895 |
| Archpoint Investors | 30 Jun 2025 | 622,409 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合